BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 18683246)

  • 1. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.
    Lee H; Park K; Kim JS; Lee SJ
    J Neurosci Res; 2009 Jan; 87(1):171-8. PubMed ID: 18683246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination.
    Lee H; Park C; Cho IH; Kim HY; Jo EK; Lee S; Kho HS; Choi SY; Oh SB; Park K; Kim JS; Lee SJ
    Glia; 2007 May; 55(7):712-22. PubMed ID: 17348024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries.
    Grant S; Lutz EM; McPhaden AR; Wadsworth RM
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine modulates the effect of neuropeptides in coeliac ganglion on ovarian hormones release: its relationship with ovarian nitric oxide and nerve growth factor.
    Garraza MH; Forneris M; Virginia Gatica L; Oliveros LB
    Neuro Endocrinol Lett; 2010; 31(1):103-12. PubMed ID: 20150881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
    Sun W; Hong J; Zang YC; Liu X; Zhang JZ
    Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
    Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration.
    Lee H; Jo EK; Choi SY; Oh SB; Park K; Kim JS; Lee SJ
    Biochem Biophys Res Commun; 2006 Nov; 350(3):742-7. PubMed ID: 17027917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells reduce survival of myenteric neurons in culture.
    Sand E; Themner-Persson A; Ekblad E
    Neuropharmacology; 2009 Feb; 56(2):522-30. PubMed ID: 19013185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
    Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.
    Zaben M; Sheward WJ; Shtaya A; Abbosh C; Harmar AJ; Pringle AK; Gray WP
    Stem Cells; 2009 Oct; 27(10):2539-51. PubMed ID: 19650041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.